JP2011507904A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011507904A5 JP2011507904A5 JP2010539885A JP2010539885A JP2011507904A5 JP 2011507904 A5 JP2011507904 A5 JP 2011507904A5 JP 2010539885 A JP2010539885 A JP 2010539885A JP 2010539885 A JP2010539885 A JP 2010539885A JP 2011507904 A5 JP2011507904 A5 JP 2011507904A5
- Authority
- JP
- Japan
- Prior art keywords
- formulation
- weight
- transdermal
- alprazolam
- patch
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000009472 formulation Methods 0.000 claims description 85
- 239000000203 mixture Substances 0.000 claims description 85
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 60
- VREFGVBLTWBCJP-UHFFFAOYSA-N alprazolam Chemical compound C12=CC(Cl)=CC=C2N2C(C)=NN=C2CN=C1C1=CC=CC=C1 VREFGVBLTWBCJP-UHFFFAOYSA-N 0.000 claims description 33
- 229960004538 alprazolam Drugs 0.000 claims description 33
- 239000013583 drug formulation Substances 0.000 claims description 29
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 24
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 claims description 20
- 229940055577 oleyl alcohol Drugs 0.000 claims description 20
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 claims description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 20
- 230000037317 transdermal delivery Effects 0.000 claims description 14
- 229940079593 drug Drugs 0.000 claims description 12
- 239000003814 drug Substances 0.000 claims description 12
- 239000002904 solvent Substances 0.000 claims description 12
- 238000002360 preparation method Methods 0.000 claims description 8
- WVLOADHCBXTIJK-YNHQPCIGSA-N hydromorphone Chemical compound O([C@H]1C(CC[C@H]23)=O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O WVLOADHCBXTIJK-YNHQPCIGSA-N 0.000 claims description 7
- 229960001410 hydromorphone Drugs 0.000 claims description 7
- RAPZEAPATHNIPO-UHFFFAOYSA-N risperidone Chemical compound FC1=CC=C2C(C3CCN(CC3)CCC=3C(=O)N4CCCCC4=NC=3C)=NOC2=C1 RAPZEAPATHNIPO-UHFFFAOYSA-N 0.000 claims description 7
- 229960001534 risperidone Drugs 0.000 claims description 7
- 208000019901 Anxiety disease Diseases 0.000 claims description 3
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 claims description 2
- 206010040880 Skin irritation Diseases 0.000 claims description 2
- 229940121363 anti-inflammatory agent Drugs 0.000 claims description 2
- 239000002260 anti-inflammatory agent Substances 0.000 claims description 2
- 230000015556 catabolic process Effects 0.000 claims description 2
- 239000003638 chemical reducing agent Substances 0.000 claims description 2
- 150000001875 compounds Chemical class 0.000 claims description 2
- 239000003246 corticosteroid Substances 0.000 claims description 2
- 229960001334 corticosteroids Drugs 0.000 claims description 2
- 238000006731 degradation reaction Methods 0.000 claims description 2
- 239000012528 membrane Substances 0.000 claims description 2
- 208000019906 panic disease Diseases 0.000 claims description 2
- 230000036556 skin irritation Effects 0.000 claims description 2
- 231100000475 skin irritation Toxicity 0.000 claims description 2
- 238000000034 method Methods 0.000 description 3
- 230000036506 anxiety Effects 0.000 description 1
- 208000020016 psychiatric disease Diseases 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US900907P | 2007-12-21 | 2007-12-21 | |
| PCT/US2008/087734 WO2009086137A1 (en) | 2007-12-21 | 2008-12-19 | Patches, formulations, and associated methods for transdermal delivery of alprazolam and other drugs |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2011507904A JP2011507904A (ja) | 2011-03-10 |
| JP2011507904A5 true JP2011507904A5 (enExample) | 2012-11-29 |
Family
ID=40824680
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010539885A Pending JP2011507904A (ja) | 2007-12-21 | 2008-12-19 | アルプラゾラムおよび他の薬物を経皮送達するためのパッチ、製剤および関連する方法 |
Country Status (4)
| Country | Link |
|---|---|
| US (2) | US8927537B2 (enExample) |
| EP (1) | EP2230911A4 (enExample) |
| JP (1) | JP2011507904A (enExample) |
| WO (1) | WO2009086137A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6131523B2 (ja) * | 2011-03-25 | 2017-05-24 | 大正製薬株式会社 | ロキソプロフェン含有外用剤 |
| JP2013060393A (ja) * | 2011-09-13 | 2013-04-04 | Nitto Denko Corp | 経皮吸収促進用組成物および貼付製剤 |
| JP5820206B2 (ja) | 2011-09-13 | 2015-11-24 | 日東電工株式会社 | 経皮吸収促進用組成物および貼付製剤 |
| JP5820207B2 (ja) | 2011-09-13 | 2015-11-24 | 日東電工株式会社 | 経皮吸収促進用組成物および貼付製剤 |
| JP5878715B2 (ja) * | 2011-09-22 | 2016-03-08 | 久光製薬株式会社 | 貼付剤 |
| JP6151935B2 (ja) * | 2013-03-11 | 2017-06-21 | 日東電工株式会社 | 経皮吸収促進用組成物および貼付製剤 |
| JP2021028294A (ja) * | 2017-09-22 | 2021-02-25 | 株式会社 メドレックス | ヒドロモルホンを薬効成分とする外用剤組成物 |
| JP2025528758A (ja) * | 2023-01-04 | 2025-09-02 | 新領医薬技術（深▲せん▼）有限公司 | リスペリドン経皮投与システム及びその製造方法と用途 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4863970A (en) | 1986-11-14 | 1989-09-05 | Theratech, Inc. | Penetration enhancement with binary system of oleic acid, oleins, and oleyl alcohol with lower alcohols |
| DE3779999T2 (de) * | 1986-11-14 | 1992-12-10 | Theratech Inc | Erhoehung des penetrationsvermoegens mittels eines aus die zellhuelle veraendernden substanzen und kurzkettigen alkoholen bestehenden binaeren systems. |
| DE3862405D1 (de) * | 1987-03-09 | 1991-05-23 | Alza Corp | Zusammensetzung zur vorbeugung einer kontaktallergie durch gleichzeitiges verabreichen eines kortikosteroids mit einem sensiblisierenden arzneistoff. |
| US4855294A (en) * | 1988-09-06 | 1989-08-08 | Theratech, Inc. | Method for reducing skin irritation associated with drug/penetration enhancer compositions |
| EP0491076A1 (en) * | 1990-12-19 | 1992-06-24 | Theratech, Inc. | Penetration enhancement with multi-component system of N-aliphatic pyrrolidones with lower alcohols |
| US5225198A (en) | 1991-08-27 | 1993-07-06 | Cygnus Therapeutic Systems | Transdermal administration of short or intermediate half-life benzodiazepines |
| FI945311L (fi) | 1992-05-13 | 1994-11-11 | Alza Corp | Oksibutyniinin transdermaalinen annostelu |
| US5503843A (en) * | 1994-04-22 | 1996-04-02 | Flora Inc. | Transdermal delivery of alpha adrenoceptor blocking agents |
| US5580574A (en) | 1994-04-28 | 1996-12-03 | Hoffmann-La Roche Inc. | Pharmaceutical composition for transdermal delivery |
| TW592729B (en) * | 1995-04-06 | 2004-06-21 | Janssen Pharmaceutica Nv | Rate-controlled transdermal administration of risperidone |
| WO1999032153A1 (en) | 1997-12-22 | 1999-07-01 | Alza Corporation | Monoglyceride and ethyl palmitate permeation enhancer compositions |
| MXPA02000053A (es) * | 1999-07-05 | 2003-07-21 | Idea Ag | Un metodo para mejorar el tratamiento a traves de barreras adaptables semipermeables. |
| US20070225379A1 (en) | 2001-08-03 | 2007-09-27 | Carrara Dario Norberto R | Transdermal delivery of systemically active central nervous system drugs |
| WO2002011768A1 (en) | 2000-08-03 | 2002-02-14 | Antares Pharma Ipl Ag | Novel composition for transdermal and/or transmucosal administration of active compounds that ensures adequate therapeutic levels |
| US8790689B2 (en) | 2003-04-30 | 2014-07-29 | Purdue Pharma L.P. | Tamper resistant transdermal dosage form |
| AU2004283431B2 (en) | 2003-10-10 | 2009-09-10 | Antares Pharma Ipl Ag | Transdermal pharmaceutical formulation for minimizing skin residues |
| US20050244522A1 (en) | 2004-04-30 | 2005-11-03 | Carrara Dario Norberto R | Permeation enhancer comprising genus Curcuma or germacrone for transdermal and topical administration of active agents |
| BRPI0611134A2 (pt) | 2005-06-03 | 2010-08-17 | Acrux Dds Pty Ltd | método e composição para liberação transdérmica de fármaco |
-
2008
- 2008-12-19 JP JP2010539885A patent/JP2011507904A/ja active Pending
- 2008-12-19 EP EP08867159.9A patent/EP2230911A4/en not_active Withdrawn
- 2008-12-19 WO PCT/US2008/087734 patent/WO2009086137A1/en not_active Ceased
- 2008-12-19 US US12/340,246 patent/US8927537B2/en not_active Expired - Fee Related
-
2014
- 2014-12-02 US US14/557,799 patent/US20150202207A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5542665B2 (ja) | マトリックス型経皮投与剤およびその製造方法 | |
| JP2011507904A5 (enExample) | ||
| US8741332B2 (en) | Compositions and methods for dermally treating neuropathic pain | |
| US8907153B2 (en) | Adhesive peel-forming formulations for dermal delivery of drugs and methods of using the same | |
| JP5020061B2 (ja) | 経皮吸収型製剤 | |
| US8821920B2 (en) | Therapeutic patch for transdermal delivery of capsaicin | |
| US20070280972A1 (en) | Adhesive solid gel-forming formulations for dermal drug delivery | |
| US20080019927A1 (en) | Compositions and methods for dermally treating neuropathy with minoxidil | |
| JP5248040B2 (ja) | ５−メチル−１−フェニル−２−（１ｈ）−ピリドン含有貼付剤 | |
| TW200800223A (en) | Transdermal delivery of meptazinol | |
| JP2009280627A5 (enExample) | ||
| JP2017039781A5 (enExample) | ||
| ES2261178T3 (es) | Una composicion transdermal de un agente anti-vomito y una preparacion de la misma. | |
| JP2011510001A (ja) | イミキモド製剤 | |
| JP2010513500A5 (enExample) | ||
| EP3527205B1 (en) | Water-based adhesive patch | |
| JP2011507904A (ja) | アルプラゾラムおよび他の薬物を経皮送達するためのパッチ、製剤および関連する方法 | |
| CN101455654A (zh) | 精氨酸布洛芬凝胶剂及其制备方法 | |
| CN110139641B (zh) | 外用组合物 | |
| JP2016513665A5 (enExample) | ||
| CN102970974B (zh) | 用于治疗皮炎和牛皮癣的去炎松缩酮制剂 | |
| JP2002537257A5 (enExample) | ||
| CN113730377A (zh) | 一种含双氯芬酸依泊胺的透皮贴剂及其制备方法 | |
| CN107684552B (zh) | 一种依托芬那酯贴剂 | |
| JP5872060B2 (ja) | Ｐｄｅ−５インヒビターの経皮送達を増強するための方法および改良された医薬組成物 |